Learn more about the Registry
Alternatively, call the registry team toll-free at
1-877-311-3770 (hours of operation 8.30am – 5.00 pm EST Monday-Friday)
Are you pregnant and diagnosed with moderate-to-severe atopic dermatitis? Have you taken CIBINQO (abrocitinib) or other medications for the treatment of moderate-to-severe atopic dermatitis during your pregnancy?
Moderate-to-severe atopic dermatitis can be a debilitating condition. Help future pregnant women, doctors, and researchers understand the safety of medications to treat atopic dermatitis.
I am a PatientAre you a healthcare provider who treats pregnant women with moderate-to-severe atopic dermatitis?
Help us learn more about the safety of using CIBINQO (abrocitinib) and other medications for the treatment of moderate-to-severe atopic dermatitis during pregnancy.
I am a Healthcare ProviderAbout the CIBINQO Pregnancy Registry
A pregnancy registry is a study that collects health information from women who take prescription medicines when they are pregnant. Information is also collected on the newborn baby. This information is compared with women who have not taken medicine or have taken other medicines during pregnancy.
The goal of the CIBINQO Pregnancy Registry is to help healthcare providers, patients, and researchers better understand the safety of CIBINQO (abrocitinib) and other medications for the treatment of moderate-to-severe atopic dermatitis during pregnancy. Pregnant women in the United States with moderate-to-severe atopic dermatitis may be eligible to participate.
Would you like to participate?
